Fig. 1: Survival outcomes and health-related quality of life in SAA patients who underwent URD-HSCT or IST + EPAG. | Blood Cancer Journal

Fig. 1: Survival outcomes and health-related quality of life in SAA patients who underwent URD-HSCT or IST + EPAG.

From: Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia

Fig. 1

A FFS in the two cohorts; B FFS in 15–20 years group; C FFS in 21–35 years group; D FFS in 36–55 years group; E FFS in SAA group; F FFS in VSAA group; G GFFS/CROS in the two cohorts; H GFFS/CROS in the 15–20 years group; I GFFS/CROS in the 21–35 years group; J GFFS/CROS in the 36–55 years group; K GFFS/CROS in SAA group; L GFFS/CROS in VSAA group; M health-related quality of life in the two groups. PCS physical component summary, PF physical functioning, RF role-physical functioning, BP bodily pain, GH general health, MCS mental component summary, SF social functioning, RF role-emotional functioning, MH mental health.

Back to article page